People · Operator
Named in public records as an officer, director or promoter · active 2009–2024 · Healthtech, Software / Tech, Other Health Care, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Trice Medical, Inc. | — | Healthtech | Series C | $124.2M | $115.8M | 2012 |
| BioSig Technologies, Inc. | — | Software / Tech | Series A | $65.7M | $3.4M | 2013 |
| NeuroClear Technologies, Inc. | — | Software / Tech | Series A | $14.9M | $298.2M | 2019 |
| Micro Interventional Devices, Inc. | — | Other Health Care | Series A | $14.0M | $119.0M | 2022 |
| Algorithm Sciences, Inc. | — | Biotechnology | Seed | $7.2M | $1.9M | 2021 |
| Embrella Cardiovascular Inc | — | Biotechnology | Series A | $6.6M | $54.2M | 2009 |
| Aerwave Medical, Inc. | — | Healthtech | Seed | $5.5M | $45.1M | 2021 |
Jeffrey O'Donnell at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jeffrey O'Donnell on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Patrick Gallagher | 3 | 11 |
| Anthony Zook | 3 | 4 |
| Jerome Zeldis | 2 | 6 |
| Kenneth Londoner | 2 | 5 |
| Matthew Duffy | 2 | 5 |
| James Ahern | 2 | 4 |
| Samuel Navarro | 2 | 4 |
| Craig K. Carra | 2 | 2 |
| Steve Chaussy | 2 | 2 |
| Garheng Kong | 1 | 16 |
| Gary Kurtzman | 1 | 8 |
| Roy Tanaka | 1 | 6 |
| Michael Dougherty | 1 | 6 |
| Steven King | 1 | 6 |
| Mark Foster | 1 | 6 |
| Jeffrey F. O'Donnell, Sr. | 1 | 5 |
| Michael Henson | 1 | 5 |
| Randy Scott | 1 | 5 |
| Dennis Purcell | 1 | 5 |
| William A Hawkins | 1 | 4 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.